 | • レポートコード：QFJ1-3939 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、乳がん分子病理学診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（PCR、FISH、DNAシーケンシング、ジーンチップ）、用途別市場規模（臨床診断、薬物スクリーニング、研究所）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・乳がん分子病理学診断の市場動向 ・企業の競争状況、市場シェア ・乳がん分子病理学診断の種類別市場規模と予測2016-2027（PCR、FISH、DNAシーケンシング、ジーンチップ） ・乳がん分子病理学診断の用途別市場規模と予測2016-2027（臨床診断、薬物スクリーニング、研究所） ・乳がん分子病理学診断の北米市場規模2016-2027（アメリカ、カナダ） ・乳がん分子病理学診断の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・乳がん分子病理学診断のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・乳がん分子病理学診断の中南米市場規模2016-2027（メキシコ、ブラジル） ・乳がん分子病理学診断の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Roche、Qiagen、Illumina、Abbott、Oncotypeiq、BD、Tellgen、Genetech、Gpmedical、Zeesan、Sansure） ・結論 |
A molecular approach for women to diagnose breast cancer
Market Analysis and Insights: Global Breast Cancer Molecular Diagnostics Market
The global Breast Cancer Molecular Diagnostics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Breast Cancer Molecular Diagnostics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Breast Cancer Molecular Diagnostics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Breast Cancer Molecular Diagnostics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Breast Cancer Molecular Diagnostics market.
Global Breast Cancer Molecular Diagnostics Scope and Market Size
Breast Cancer Molecular Diagnostics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Breast Cancer Molecular Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
PCR
FISH
DNA Sequencing
Gene Chip
Segment by Application
Clinical Diagnosis
Drug Screening
Research
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Roche
Qiagen
Illumina
Abbott
Oncotypeiq
BD
Tellgen
Genetech
Gpmedical
Zeesan
Sansure
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Breast Cancer Molecular Diagnostics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 PCR
1.2.3 FISH
1.2.4 DNA Sequencing
1.2.5 Gene Chip
1.3 Market by Application
1.3.1 Global Breast Cancer Molecular Diagnostics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Clinical Diagnosis
1.3.3 Drug Screening
1.3.4 Research
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Breast Cancer Molecular Diagnostics Market Perspective (2016-2027)
2.2 Breast Cancer Molecular Diagnostics Growth Trends by Regions
2.2.1 Breast Cancer Molecular Diagnostics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Breast Cancer Molecular Diagnostics Historic Market Share by Regions (2016-2021)
2.2.3 Breast Cancer Molecular Diagnostics Forecasted Market Size by Regions (2022-2027)
2.3 Breast Cancer Molecular Diagnostics Industry Dynamic
2.3.1 Breast Cancer Molecular Diagnostics Market Trends
2.3.2 Breast Cancer Molecular Diagnostics Market Drivers
2.3.3 Breast Cancer Molecular Diagnostics Market Challenges
2.3.4 Breast Cancer Molecular Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Breast Cancer Molecular Diagnostics Players by Revenue
3.1.1 Global Top Breast Cancer Molecular Diagnostics Players by Revenue (2016-2021)
3.1.2 Global Breast Cancer Molecular Diagnostics Revenue Market Share by Players (2016-2021)
3.2 Global Breast Cancer Molecular Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Breast Cancer Molecular Diagnostics Revenue
3.4 Global Breast Cancer Molecular Diagnostics Market Concentration Ratio
3.4.1 Global Breast Cancer Molecular Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Breast Cancer Molecular Diagnostics Revenue in 2020
3.5 Breast Cancer Molecular Diagnostics Key Players Head office and Area Served
3.6 Key Players Breast Cancer Molecular Diagnostics Product Solution and Service
3.7 Date of Enter into Breast Cancer Molecular Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Breast Cancer Molecular Diagnostics Breakdown Data by Type
4.1 Global Breast Cancer Molecular Diagnostics Historic Market Size by Type (2016-2021)
4.2 Global Breast Cancer Molecular Diagnostics Forecasted Market Size by Type (2022-2027)
5 Breast Cancer Molecular Diagnostics Breakdown Data by Application
5.1 Global Breast Cancer Molecular Diagnostics Historic Market Size by Application (2016-2021)
5.2 Global Breast Cancer Molecular Diagnostics Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Breast Cancer Molecular Diagnostics Market Size (2016-2027)
6.2 North America Breast Cancer Molecular Diagnostics Market Size by Type
6.2.1 North America Breast Cancer Molecular Diagnostics Market Size by Type (2016-2021)
6.2.2 North America Breast Cancer Molecular Diagnostics Market Size by Type (2022-2027)
6.2.3 North America Breast Cancer Molecular Diagnostics Market Size by Type (2016-2027)
6.3 North America Breast Cancer Molecular Diagnostics Market Size by Application
6.3.1 North America Breast Cancer Molecular Diagnostics Market Size by Application (2016-2021)
6.3.2 North America Breast Cancer Molecular Diagnostics Market Size by Application (2022-2027)
6.3.3 North America Breast Cancer Molecular Diagnostics Market Size by Application (2016-2027)
6.4 North America Breast Cancer Molecular Diagnostics Market Size by Country
6.4.1 North America Breast Cancer Molecular Diagnostics Market Size by Country (2016-2021)
6.4.2 North America Breast Cancer Molecular Diagnostics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Breast Cancer Molecular Diagnostics Market Size (2016-2027)
7.2 Europe Breast Cancer Molecular Diagnostics Market Size by Type
7.2.1 Europe Breast Cancer Molecular Diagnostics Market Size by Type (2016-2021)
7.2.2 Europe Breast Cancer Molecular Diagnostics Market Size by Type (2022-2027)
7.2.3 Europe Breast Cancer Molecular Diagnostics Market Size by Type (2016-2027)
7.3 Europe Breast Cancer Molecular Diagnostics Market Size by Application
7.3.1 Europe Breast Cancer Molecular Diagnostics Market Size by Application (2016-2021)
7.3.2 Europe Breast Cancer Molecular Diagnostics Market Size by Application (2022-2027)
7.3.3 Europe Breast Cancer Molecular Diagnostics Market Size by Application (2016-2027)
7.4 Europe Breast Cancer Molecular Diagnostics Market Size by Country
7.4.1 Europe Breast Cancer Molecular Diagnostics Market Size by Country (2016-2021)
7.4.2 Europe Breast Cancer Molecular Diagnostics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Breast Cancer Molecular Diagnostics Market Size (2016-2027)
8.2 Asia-Pacific Breast Cancer Molecular Diagnostics Market Size by Type
8.2.1 Asia-Pacific Breast Cancer Molecular Diagnostics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Breast Cancer Molecular Diagnostics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Breast Cancer Molecular Diagnostics Market Size by Type (2016-2027)
8.3 Asia-Pacific Breast Cancer Molecular Diagnostics Market Size by Application
8.3.1 Asia-Pacific Breast Cancer Molecular Diagnostics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Breast Cancer Molecular Diagnostics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Breast Cancer Molecular Diagnostics Market Size by Application (2016-2027)
8.4 Asia-Pacific Breast Cancer Molecular Diagnostics Market Size by Region
8.4.1 Asia-Pacific Breast Cancer Molecular Diagnostics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Breast Cancer Molecular Diagnostics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Breast Cancer Molecular Diagnostics Market Size (2016-2027)
9.2 Latin America Breast Cancer Molecular Diagnostics Market Size by Type
9.2.1 Latin America Breast Cancer Molecular Diagnostics Market Size by Type (2016-2021)
9.2.2 Latin America Breast Cancer Molecular Diagnostics Market Size by Type (2022-2027)
9.2.3 Latin America Breast Cancer Molecular Diagnostics Market Size by Type (2016-2027)
9.3 Latin America Breast Cancer Molecular Diagnostics Market Size by Application
9.3.1 Latin America Breast Cancer Molecular Diagnostics Market Size by Application (2016-2021)
9.3.2 Latin America Breast Cancer Molecular Diagnostics Market Size by Application (2022-2027)
9.3.3 Latin America Breast Cancer Molecular Diagnostics Market Size by Application (2016-2027)
9.4 Latin America Breast Cancer Molecular Diagnostics Market Size by Country
9.4.1 Latin America Breast Cancer Molecular Diagnostics Market Size by Country (2016-2021)
9.4.2 Latin America Breast Cancer Molecular Diagnostics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Breast Cancer Molecular Diagnostics Market Size (2016-2027)
10.2 Middle East & Africa Breast Cancer Molecular Diagnostics Market Size by Type
10.2.1 Middle East & Africa Breast Cancer Molecular Diagnostics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Breast Cancer Molecular Diagnostics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Breast Cancer Molecular Diagnostics Market Size by Type (2016-2027)
10.3 Middle East & Africa Breast Cancer Molecular Diagnostics Market Size by Application
10.3.1 Middle East & Africa Breast Cancer Molecular Diagnostics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Breast Cancer Molecular Diagnostics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Breast Cancer Molecular Diagnostics Market Size by Application (2016-2027)
10.4 Middle East & Africa Breast Cancer Molecular Diagnostics Market Size by Country
10.4.1 Middle East & Africa Breast Cancer Molecular Diagnostics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Breast Cancer Molecular Diagnostics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Breast Cancer Molecular Diagnostics Introduction
11.1.4 Roche Revenue in Breast Cancer Molecular Diagnostics Business (2016-2021)
11.1.5 Roche Recent Development
11.2 Qiagen
11.2.1 Qiagen Company Details
11.2.2 Qiagen Business Overview
11.2.3 Qiagen Breast Cancer Molecular Diagnostics Introduction
11.2.4 Qiagen Revenue in Breast Cancer Molecular Diagnostics Business (2016-2021)
11.2.5 Qiagen Recent Development
11.3 Illumina
11.3.1 Illumina Company Details
11.3.2 Illumina Business Overview
11.3.3 Illumina Breast Cancer Molecular Diagnostics Introduction
11.3.4 Illumina Revenue in Breast Cancer Molecular Diagnostics Business (2016-2021)
11.3.5 Illumina Recent Development
11.4 Abbott
11.4.1 Abbott Company Details
11.4.2 Abbott Business Overview
11.4.3 Abbott Breast Cancer Molecular Diagnostics Introduction
11.4.4 Abbott Revenue in Breast Cancer Molecular Diagnostics Business (2016-2021)
11.4.5 Abbott Recent Development
11.5 Oncotypeiq
11.5.1 Oncotypeiq Company Details
11.5.2 Oncotypeiq Business Overview
11.5.3 Oncotypeiq Breast Cancer Molecular Diagnostics Introduction
11.5.4 Oncotypeiq Revenue in Breast Cancer Molecular Diagnostics Business (2016-2021)
11.5.5 Oncotypeiq Recent Development
11.6 BD
11.6.1 BD Company Details
11.6.2 BD Business Overview
11.6.3 BD Breast Cancer Molecular Diagnostics Introduction
11.6.4 BD Revenue in Breast Cancer Molecular Diagnostics Business (2016-2021)
11.6.5 BD Recent Development
11.7 Tellgen
11.7.1 Tellgen Company Details
11.7.2 Tellgen Business Overview
11.7.3 Tellgen Breast Cancer Molecular Diagnostics Introduction
11.7.4 Tellgen Revenue in Breast Cancer Molecular Diagnostics Business (2016-2021)
11.7.5 Tellgen Recent Development
11.8 Genetech
11.8.1 Genetech Company Details
11.8.2 Genetech Business Overview
11.8.3 Genetech Breast Cancer Molecular Diagnostics Introduction
11.8.4 Genetech Revenue in Breast Cancer Molecular Diagnostics Business (2016-2021)
11.8.5 Genetech Recent Development
11.9 Gpmedical
11.9.1 Gpmedical Company Details
11.9.2 Gpmedical Business Overview
11.9.3 Gpmedical Breast Cancer Molecular Diagnostics Introduction
11.9.4 Gpmedical Revenue in Breast Cancer Molecular Diagnostics Business (2016-2021)
11.9.5 Gpmedical Recent Development
11.10 Zeesan
11.10.1 Zeesan Company Details
11.10.2 Zeesan Business Overview
11.10.3 Zeesan Breast Cancer Molecular Diagnostics Introduction
11.10.4 Zeesan Revenue in Breast Cancer Molecular Diagnostics Business (2016-2021)
11.10.5 Zeesan Recent Development
11.11 Sansure
11.11.1 Sansure Company Details
11.11.2 Sansure Business Overview
11.11.3 Sansure Breast Cancer Molecular Diagnostics Introduction
11.11.4 Sansure Revenue in Breast Cancer Molecular Diagnostics Business (2016-2021)
11.11.5 Sansure Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Breast Cancer Molecular Diagnostics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of PCR
Table 3. Key Players of FISH
Table 4. Key Players of DNA Sequencing
Table 5. Key Players of Gene Chip
Table 6. Global Breast Cancer Molecular Diagnostics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Breast Cancer Molecular Diagnostics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Breast Cancer Molecular Diagnostics Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Breast Cancer Molecular Diagnostics Market Share by Regions (2016-2021)
Table 10. Global Breast Cancer Molecular Diagnostics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Breast Cancer Molecular Diagnostics Market Share by Regions (2022-2027)
Table 12. Breast Cancer Molecular Diagnostics Market Trends
Table 13. Breast Cancer Molecular Diagnostics Market Drivers
Table 14. Breast Cancer Molecular Diagnostics Market Challenges
Table 15. Breast Cancer Molecular Diagnostics Market Restraints
Table 16. Global Breast Cancer Molecular Diagnostics Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Breast Cancer Molecular Diagnostics Market Share by Players (2016-2021)
Table 18. Global Top Breast Cancer Molecular Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Breast Cancer Molecular Diagnostics as of 2020)
Table 19. Ranking of Global Top Breast Cancer Molecular Diagnostics Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Breast Cancer Molecular Diagnostics Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Breast Cancer Molecular Diagnostics Product Solution and Service
Table 23. Date of Enter into Breast Cancer Molecular Diagnostics Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Breast Cancer Molecular Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Breast Cancer Molecular Diagnostics Revenue Market Share by Type (2016-2021)
Table 27. Global Breast Cancer Molecular Diagnostics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Breast Cancer Molecular Diagnostics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Breast Cancer Molecular Diagnostics Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Breast Cancer Molecular Diagnostics Revenue Market Share by Application (2016-2021)
Table 31. Global Breast Cancer Molecular Diagnostics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Breast Cancer Molecular Diagnostics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Breast Cancer Molecular Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Breast Cancer Molecular Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Breast Cancer Molecular Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Breast Cancer Molecular Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Breast Cancer Molecular Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Breast Cancer Molecular Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Breast Cancer Molecular Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Breast Cancer Molecular Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Breast Cancer Molecular Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Breast Cancer Molecular Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Breast Cancer Molecular Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Breast Cancer Molecular Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Breast Cancer Molecular Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Breast Cancer Molecular Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Breast Cancer Molecular Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Breast Cancer Molecular Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Breast Cancer Molecular Diagnostics Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Breast Cancer Molecular Diagnostics Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Breast Cancer Molecular Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Breast Cancer Molecular Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Breast Cancer Molecular Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Breast Cancer Molecular Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Breast Cancer Molecular Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Breast Cancer Molecular Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Breast Cancer Molecular Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Breast Cancer Molecular Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Breast Cancer Molecular Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Breast Cancer Molecular Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Breast Cancer Molecular Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Breast Cancer Molecular Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 63. Roche Company Details
Table 64. Roche Business Overview
Table 65. Roche Breast Cancer Molecular Diagnostics Product
Table 66. Roche Revenue in Breast Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 67. Roche Recent Development
Table 68. Qiagen Company Details
Table 69. Qiagen Business Overview
Table 70. Qiagen Breast Cancer Molecular Diagnostics Product
Table 71. Qiagen Revenue in Breast Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 72. Qiagen Recent Development
Table 73. Illumina Company Details
Table 74. Illumina Business Overview
Table 75. Illumina Breast Cancer Molecular Diagnostics Product
Table 76. Illumina Revenue in Breast Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 77. Illumina Recent Development
Table 78. Abbott Company Details
Table 79. Abbott Business Overview
Table 80. Abbott Breast Cancer Molecular Diagnostics Product
Table 81. Abbott Revenue in Breast Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 82. Abbott Recent Development
Table 83. Oncotypeiq Company Details
Table 84. Oncotypeiq Business Overview
Table 85. Oncotypeiq Breast Cancer Molecular Diagnostics Product
Table 86. Oncotypeiq Revenue in Breast Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 87. Oncotypeiq Recent Development
Table 88. BD Company Details
Table 89. BD Business Overview
Table 90. BD Breast Cancer Molecular Diagnostics Product
Table 91. BD Revenue in Breast Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 92. BD Recent Development
Table 93. Tellgen Company Details
Table 94. Tellgen Business Overview
Table 95. Tellgen Breast Cancer Molecular Diagnostics Product
Table 96. Tellgen Revenue in Breast Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 97. Tellgen Recent Development
Table 98. Genetech Company Details
Table 99. Genetech Business Overview
Table 100. Genetech Revenue in Breast Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 101. Genetech Recent Development
Table 102. Gpmedical Company Details
Table 103. Gpmedical Business Overview
Table 104. Gpmedical Breast Cancer Molecular Diagnostics Product
Table 105. Gpmedical Revenue in Breast Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 106. Gpmedical Recent Development
Table 107. Zeesan Company Details
Table 108. Zeesan Business Overview
Table 109. Zeesan Breast Cancer Molecular Diagnostics Product
Table 110. Zeesan Revenue in Breast Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 111. Zeesan Recent Development
Table 112. Sansure Company Details
Table 113. Sansure Business Overview
Table 114. Sansure Breast Cancer Molecular Diagnostics Product
Table 115. Sansure Revenue in Breast Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 116. Sansure Recent Development
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Breast Cancer Molecular Diagnostics Market Share by Type: 2020 VS 2027
Figure 2. PCR Features
Figure 3. FISH Features
Figure 4. DNA Sequencing Features
Figure 5. Gene Chip Features
Figure 6. Global Breast Cancer Molecular Diagnostics Market Share by Application: 2020 VS 2027
Figure 7. Clinical Diagnosis Case Studies
Figure 8. Drug Screening Case Studies
Figure 9. Research Case Studies
Figure 10. Breast Cancer Molecular Diagnostics Report Years Considered
Figure 11. Global Breast Cancer Molecular Diagnostics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Breast Cancer Molecular Diagnostics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Breast Cancer Molecular Diagnostics Market Share by Regions: 2020 VS 2027
Figure 14. Global Breast Cancer Molecular Diagnostics Market Share by Regions (2022-2027)
Figure 15. Global Breast Cancer Molecular Diagnostics Market Share by Players in 2020
Figure 16. Global Top Breast Cancer Molecular Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Breast Cancer Molecular Diagnostics as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Breast Cancer Molecular Diagnostics Revenue in 2020
Figure 18. Global Breast Cancer Molecular Diagnostics Revenue Market Share by Type (2016-2021)
Figure 19. Global Breast Cancer Molecular Diagnostics Revenue Market Share by Type (2022-2027)
Figure 20. North America Breast Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Breast Cancer Molecular Diagnostics Market Share by Type (2016-2027)
Figure 22. North America Breast Cancer Molecular Diagnostics Market Share by Application (2016-2027)
Figure 23. North America Breast Cancer Molecular Diagnostics Market Share by Country (2016-2027)
Figure 24. United States Breast Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Breast Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Breast Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Breast Cancer Molecular Diagnostics Market Share by Type (2016-2027)
Figure 28. Europe Breast Cancer Molecular Diagnostics Market Share by Application (2016-2027)
Figure 29. Europe Breast Cancer Molecular Diagnostics Market Share by Country (2016-2027)
Figure 30. Germany Breast Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Breast Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Breast Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Breast Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Breast Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Breast Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Breast Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Breast Cancer Molecular Diagnostics Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Breast Cancer Molecular Diagnostics Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Breast Cancer Molecular Diagnostics Market Share by Region (2016-2027)
Figure 40. China Breast Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Breast Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Breast Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Breast Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Breast Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Breast Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Breast Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Breast Cancer Molecular Diagnostics Market Share by Type (2016-2027)
Figure 48. Latin America Breast Cancer Molecular Diagnostics Market Share by Application (2016-2027)
Figure 49. Latin America Breast Cancer Molecular Diagnostics Market Share by Country (2016-2027)
Figure 50. Mexico Breast Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Breast Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Breast Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Breast Cancer Molecular Diagnostics Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Breast Cancer Molecular Diagnostics Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Breast Cancer Molecular Diagnostics Market Share by Country (2016-2027)
Figure 56. Turkey Breast Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Breast Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Breast Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Roche Revenue Growth Rate in Breast Cancer Molecular Diagnostics Business (2016-2021)
Figure 60. Qiagen Revenue Growth Rate in Breast Cancer Molecular Diagnostics Business (2016-2021)
Figure 61. Illumina Revenue Growth Rate in Breast Cancer Molecular Diagnostics Business (2016-2021)
Figure 62. Abbott Revenue Growth Rate in Breast Cancer Molecular Diagnostics Business (2016-2021)
Figure 63. Oncotypeiq Revenue Growth Rate in Breast Cancer Molecular Diagnostics Business (2016-2021)
Figure 64. BD Revenue Growth Rate in Breast Cancer Molecular Diagnostics Business (2016-2021)
Figure 65. Tellgen Revenue Growth Rate in Breast Cancer Molecular Diagnostics Business (2016-2021)
Figure 66. Genetech Revenue Growth Rate in Breast Cancer Molecular Diagnostics Business (2016-2021)
Figure 67. Gpmedical Revenue Growth Rate in Breast Cancer Molecular Diagnostics Business (2016-2021)
Figure 68. Zeesan Revenue Growth Rate in Breast Cancer Molecular Diagnostics Business (2016-2021)
Figure 69. Sansure Revenue Growth Rate in Breast Cancer Molecular Diagnostics Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
世界の皮膚がん分子診断市場規模・現状・予測（2021年-2027年） A molecular approach for diagnosing skin cancer Market Analysis and Insights: Global Skin Cancer Molecular Diagnostics Market The global Skin Cancer Molecular Diagnostics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With in…- 世界の喉頭がん分子診断市場規模・現状・予測（2021年-2027年） A molecular approach for diagnosing laryngeal cancer Market Analysis and Insights: Global Laryngeal Cancer Molecular Diagnostics Market The global Laryngeal Cancer Molecular Diagnostics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 202…
- 世界の膀胱がん分子病理学診断市場規模・現状・予測（2021年-2027年） A molecular approach for diagnosing bladder cancer Market Analysis and Insights: Global Bladder Cancer Molecular Diagnostics Market The global Bladder Cancer Molecular Diagnostics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027…
- 世界の膵臓がん分子診断市場規模・現状・予測（2021年-2027年） A molecular approach for diagnosing pancreatic cancer Market Analysis and Insights: Global Pancreatic Cancer Molecular Diagnostics Market The global Pancreatic Cancer Molecular Diagnostics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during …
- 世界の前立腺がん分子診断市場規模・現状・予測（2021年-2027年） A molecular approach for diagnosing prostate cancer Market Analysis and Insights: Global Prostate Cancer Molecular Diagnostics Market The global Prostate Cancer Molecular Diagnostics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2…